(Q38113249)

29 August 2017

Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence (English)

1 reference

29 August 2017

5

Jan A Staessen

1 reference

29 August 2017

Alexandre Persu

1

1 reference

29 August 2017

Jean Renkin

series ordinal

2

1 reference

29 August 2017

Kei Asayama

series ordinal

3

1 reference

29 August 2017

Eoin O'Brien

series ordinal

4

1 reference

29 August 2017

1 June 2013

1 reference

Expert Review of Cardiovascular Therapy

29 August 2017

1 reference

29 August 2017

11

1 reference

29 August 2017

6

1 reference

29 August 2017

739-749

1 reference

Hypertension Prevalence and Stroke Mortality Across Populations

29 August 2017

1 reference

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives

21 January 2018

1 reference

Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

21 January 2018

1 reference

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept

21 January 2018

1 reference

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

21 January 2018

1 reference

Renal denervation: ultima ratio or standard in treatment-resistant hypertension

21 January 2018

1 reference

Medication adherence and persistence as the cornerstone of effective antihypertensive therapy

21 January 2018

1 reference

Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

21 January 2018

1 reference

Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.

21 January 2018

1 reference

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

21 January 2018

1 reference

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

21 January 2018

1 reference

Effects of Renal Sympathetic Denervation on 24-hour Blood Pressure Variability

21 January 2018

1 reference

Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension

21 January 2018

1 reference

Renal denervation in moderate to severe CKD.

21 January 2018

1 reference

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

21 January 2018

1 reference

21 January 2018

1 reference

First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study

21 January 2018

1 reference

Renal denervation in a patient with prior renal artery stenting.

21 January 2018

1 reference

Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect

21 January 2018

1 reference

Renal artery stenosis after renal sympathetic denervation.

21 January 2018

1 reference

Renal sympathetic denervation for treatment of electrical storm: first-in-man experience.

21 January 2018

1 reference

Percutaneous transluminal renal denervation: a potential treatment option for polycystic kidney disease-related pain?

21 January 2018

1 reference

Hypertension in 2011: New insights--from risk factors to treatment implications

21 January 2018

1 reference

Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

ESH position paper: renal denervation - an interventional therapy of resistant hypertension

21 January 2018

1 reference

Expert consensus: Renal denervation for the treatment of hypertension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.13.52

1 reference

29 August 2017

1 reference